Thryvtrx
1 known investors
Thryv Therapeutics is a clinical-stage biotech company developing precision medicine treatments for genetic arrhythmia syndromes and cardiometabolic diseases using selective SGK1 inhibitors. The company focuses on cardiac conditions affecting patients with genetic disorders like Long QT Syndrome.
BiotechHealthtech